Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2026-01-02 @ 9:45 AM
Study NCT ID:
NCT01510704
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2012-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Dose-ranging Study of APD421 in PONV
Sponsor:
Acacia Pharma Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Postoperative Nausea and Vomiting | View |
Keywords: